ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RMTI vs JNJ // ALTMAN Z-SCORE & DEBT/EQUITY

Rockwell Medical Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: RMTI 0 — JNJ 8
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RMTI VS. JNJ) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RMTI JNJ SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 16.90% 67.90% -51.00 JNJ /gross-margins <GO>
Return on Invested Capital (ROIC) -10.60% 25.50% -36.10 JNJ /roic <GO>
EV/EBITDA & P/E Valuation — 18.5x — TIE /valuation <GO>
Free Cash Flow Yield -2.24% 2.97% -5.21 JNJ /fcf-yield <GO>
Operating Margin -6.80% 34.70% -41.50 JNJ /operating-margins <GO>
Net Profit Margin -7.70% 28.50% -36.20 JNJ /net-margins <GO>
Revenue Growth (YoY) — 6.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — 5.59 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 8/9 -5.00 JNJ /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 41.0 62.1 -21.11 JNJ /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 1.08 — TIE /macro-sensitivity <GO>
Forward P/E Multiple — 23.0x — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $29.5M $662.49B -$662.46B JNJ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RMTI REV JNJ REV RMTI GROSS % JNJ GROSS % RMTI FCF JNJ FCF
FY 2025 $69.3M $94.19B 16.9% 67.9% -$659.0K $19.70B
FY 2024 $101.5M $88.82B 17.2% 69.1% $4.2M $19.84B
FY 2023 $0 $85.16B — — -$9.4M $18.96B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RMTI // BETA —
JNJ // BETA 1.08